Dr. A Velumani, Thyrocare's founder, advises parents against overindulging their children, emphasizing the crucial roles of ...

Mumbai: After years of relying on external partnerships, Sion hospital is set to expand its efforts to hunt for drug-resistant tuberculosis by adding .

Investors will be watching updates from major names such as Kotak Mahindra Bank, Lodha Developers, Balkrishna Industries, ...

Franchise-led expansion has been the key driver behind Thyrocare’s strong Q1 performance, with CEO Rahul Guha attributing the 23% revenue growth and 60% profit surge to the addition of 1,500 new ...

LIC, Lupin, Divi's, 3M India, Abbott India, Fortis Healthcare, Bharti Hexacom, Union Bank, Zydus Lifesciences, Orient Cement ...

Thyrocare Technologies' shares soared 13% after reporting a 60% YoY surge in Q1 net profit, bolstered by strong operational revenue growth.

Thyrocare Technologies surged 11.30% to Rs 1,340.55 after the healthcare service provider reported a 61.07% increase in consolidated net profit to Rs 38.93 crore on a 23.02% rise in revenue from ...

Thyrocare Technologies delivered excellent results in Q1. Both the company’s revenue and profit have increased. CEO Rahul Guha expressed optimism for faster growth in FY26. In an exclusive ...

Thyrocare Technologies shares zoomed 12.66 per cent in trade, hitting a 52-week high at ₹1,356.95 per share on the BSE.

Real-time updates on THYROCARE TECHNOLOGIES share price. Check out the detailed analysis of the company in this live blog.

Net Sales at Rs 178.89 crore in June 2025 up 24.55% from Rs. 143.63 crore in June 2024. Quarterly Net Profit at Rs. 36.05 crore in June 2025 up 43.34% from Rs. 25.15 crore in June 2024. EBITDA stands ...